Drug Shortage Report for APO-DILTIAZ SR

Last updated on 2017-10-05 History
Report ID 19027
Drug Identification Number 02222957
Brand name APO-DILTIAZ SR - SRC 60MG
Common or Proper name DILTIAZEM
Company Name APOTEX INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 60MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-08-13 French Compare
v1 2017-08-13 English Compare

Showing 1 to 2 of 2